Chronic Liver Disease
description
Transcript of Chronic Liver Disease
Tim BadcockFY1 Colorectal surgery
21/10/13
Plan• Introduction to the liver• Definition• Clinical Scenario• Presentation• Aetiology• Complications• Investigations• Management• Prognosis
Introduction to the liver5 Functional
domains4 lobes3 vascular2 important
ligaments1 Biliary tree
5.Domains• Synthetic
– Albumin– Clotting factors (1972)
• Metabolism– CYP350 drugs– Gluconeogenesis/glycogenesis/glycogenolysis– Homeostasis– Iron, copper, vitamin K
• Vascular• Immunological
– Kuppfer cells beside sinusoids• Biliary tree
– Bilirubin– Left/right hepatic = common hepatic duct– Common hepatic + bile duct = common bile duct– Common bile duct + pancreatic duct
4. LobesLeftRightCaudateQuadrate
3. Vascular structuresHepatic portal vein (80%) Hepatic artery (18%)Hepatic vein (2%)
2. LigamentsFalciform (developmental structure of liver,
umbilical vein) Venosum (ductus venosus)
1. Biliary tree
1
87
56
9
3
4
2
Definition• Acute/chronic, organ system, key
characteristics• A chronic reduction in hepatic function
characterised by poor synthetic, metabolic, and immunological functions and vascular compromise associated with ascites and portal hypertension.
• Also associated with acute decompensation events characterised by acute haemorrhage, severe abdominal infection, neurological impairment and oedema
TimingHyperacute (<1week)Acute liver failure (7-28 days)Fulminant liver failure
(1 month-6 months)Chronic (>6 months)
Clinical scenario• 54 year old gentleman presents to his GP with
increasing swelling of his abdomen and feet over the last 2 months. He has been increasing tired over this time and feels nauseous and is off his food. His wife has commented that his eye have turned yellow over the last few days. He works in a warehouse and smokes 10 cigarettes a day. He admits to drinking 4 cans of lager a night. His wife says he drinks at least 8 cans a night and a bottle of whiskey a week. He noticed that he bled profusely when he cuaght himself on a baked beans can
Case study On examination he has pale white nails and a
slghtly bent 4th finger. He has man boobs. He is jaundiced but has no hepatic flap and is orientated in time, place and person. His abdomen is distended but soft and non-tender. There is no palpable organomegaly but there is shifting dullness. A raised JVP is noted on hepatic compression
Presentation• Synthetic
– Albumin – ascites, infection– Clotting - variceal bleed, haematemesis, meleana
• Metabolism• Bilirubin – jaundice• CYP450 drugs – variable INR, toxicity
• ODEVICES = inhibitor• PCBRAS – inducer
• Hepatic encephalopathy• Hypoglycaemic• Hormones – high oestrogen• Syndromes
SyndromesAutoantibodies against hepatocytes. Often young women
with other autoimmune conditions. RUQ pain and jaundiceα1- antitrypsin deficiency (early severe fibrosis)Primary biliary cirrhosis (AMA, young women
autoimmune)Primary sclerosing choloangitis (ANA,Haemochromatosis – early onset jaundice, bronze
diabetesWilson’s disease – Keyser-Flescher, serum
caeruloplasminGilbert Syndrome (UDP glucoronyl transferase, early
mild jaundice)Crigler Nijjar syndrome (severe early, kernicterus)
PresentationVascular
Hepatomegaly (RUQ pain)SplenomegalyHaematesis (oesophageal varices)Meleana
ImmunologicalSpontaneous bacterial peritonitis
Biliary treeJaundice
Pre-hepatic (dark stools)
Hepatic (dark urine, normal/pale stools)
Obstructive (dark urine, pale stools)
Urobilinogen/stercobilinogen
Signs
Aetiology• Alcoholic liver disease• Non-alcoholic fatty liver disease• Viral liver disease• Primiary biliary sclerosis, Primary sclerosing
cholangitis, Wilson’s, HH etc• Hepatocellular Carcinoma (rare, UC)• Metastasis (common)/ Pancreatic cancer
(rare) • Cryptogenic Liver Cirrhosis
PathophysiologyChronic inflammatory (swelling, fatty infiltraton,
cytoplasm granulation)Eosinophil and macrophage invasionLytic necrosisFibrosis and contractureLoss of liver architecture
SinusoidsAciniiPortal triad
Alcoholic fatty liver diseaseHigh calorie intake in alcoholFat droplets deposit in hepatocytesEthanol directly affects cell membrane
stability as does aldehydeChronic necrosis of cells with fibrosis
Later becomes small cirrhotic liver
Non-alcoholic fatty liver disease5% population, asymptomaticSeen on US abdo/biopsy
Diabetes MellitusMetabolic syndrome (HTN,
hypercholesteraemia, diabetes)Pregnancy (high oestrogen)Idiopathic
Oxidative stress and steatohepatitis
Hepatitis B & CHepatitis B & CHepatitis B & CHepatitis B & CHepatitis B Hepatitis C
Virus DNA RNA
Spread Blood, sexual Blood
Presentation Fever, malaise, anorexia, nausea, arthralgia, jaundice, RUQ pain
Usually asymptomatic early on
Investigation See below. Biopsy Anti-HCV, HCV DNA. Biopsy.
% Chronic 5-10% 85%
Treatment Supportive. Chronic: antivirals (nucleoside analogues). Transplant
Nucleoside analogues, protease inhibitors (anti-retroviral). Liver transplant
HbcAg = core antigen = replicatingHBeAg = pre-core antigen = current infectionHBsAg = surface antigen = acute/chronicHBV DNA = infectious
Anti-HBc = active infectionAnti-HBe = latent infection if HBeAg +ve
vaccinated if HBeAg -ve
ComplicationsPortal hypertensionDiabetesSpontaneous bacterial peritonealHepatic encephalopathyLiver transplantMalnutritionRenal failure
Portal hypertensionOesophageal varices (azygous veins)Rectal varices (inferior rectal veins)Caput medusae (umbilical veins)Budd-Chiari syndrome (hepatic vein thrombosis)
TIPSS (transjugular intrahepatic portosystemic shunt)
OGD +/- Variceal banding, stent, sclerotherapyMassive haemorrhage protocol
DiabetesPoor glucose storageBronze diabetes
Diabetic therapyDietary modification
Spontaneous bacterial peritoneal8% ascitesSevere abdominal painSeverely unwell
Ascitic tapPeritoneal lavageIntravenous antibioticsLiver transplant
Hepatic encephalopathy Increased ammonia from bacterial activity on protein in faeces Liver bypass (TIPSS) Haemorrhage
Foetor hepaticus Hepatic flap (asterix) Decreased mental capacity e.g. Constructional apraxia
West Haven Criteria Grade I altered mood/behaviour Grade II reduced consciousness Grade III Stupor Grade IV Coma
Enemas, lactulose, niacin, IV fluids
Liver transplantEnd stage liver failureSBPCongenital syndromes
Strict criteria for transplant
Long term immunosuppresants (azathioprine, ciclosporin)
Avoid alcohol
MalnutritionEncourage highest possible protein intakeHigh calorie intakeAvoid alcoholChlordiazepoxideAcamprosateDisulfiram
Renal failureIncreased vascular pressure from portal
hypertension into splenic and renal veinsDiabetic nephrotic syndrome – minimal
changeHepatorenal syndrome – low oncotic pressure
triggers peripheral hypovolaemia, neuropepetide Y and RAAS activation leads to constriction of afferent and dilatation of efferent arterioles leading to renal hypoperfusion
InvestigationsBiological
BedsideBloodsImagingSpecial
PsychologicalAlcohol addictionDepression
SocialUnemploymentSupportive housing
Biological Bedside
Observations (BP, pyrexia, BM) ECG ABG GCS/West Haven
Bloods FBC (anaemia, WCC) U&Es (urea, creatinine) LFTs (all important) Clotting (intrinsic and
extrinsic) CRP (infective) Cholesterol (fatty) HbA1c Gamma GT (alcohol) Antibodies
• Imaging• US Abdomen• CT abdomen• CT angiography• CXR• ERCP
• Special• Drugs e.g. paracetemol• OGD (varices)• Hepatitis
screen/leptospirosis• Ascitic tap• Liver biopsy (cancer,
severity)• PET scan (mets)• Colnoscopy (ulcerative
colitis)
Liver function testsTotal protein = albumin + globinsAlbumin – long term syntheticBilirubin – bile production/retention, Gilberts/Crigler
Nijjar, Sickle cell, Iatrogenic - carbimazoleALP – bile duct inflammation + bone +
hyperoestrogenic states, drugsALT – hepatocyte inflammaion + thyroid
dysregulation + coeliac + exercise
Clotting – INR, APTTExtras – amylase, gGT, paracetemol (NAC)
Acute ManagementPersonal Alcohol abstinence Fluid restriction 10% dextrose infusion/sliding scale Raise head of bed
Medical Jaundice – urseodoexycholic acid ,
colystyramine reduces pruritus Alcohol complications - Pabrinex
(IV/PO), chlordiazepoxide Ascites – Diuretics, Paracentesis, NG
feeding Ulceration – omeprazole Bleeding – vitamin K/octaplex Wilsons’s - penicillamine
• Hepatic encephlopathy – laxatives, antibiotics, IV fluids (avoid NaCl), mannitol
• SBP – antibiotics e.g. tazocin
Surgical• TIPSS• Peritoneal lavage/ascitic tap
Chronic managementPersonal Alcohol abstinence Optimise nutrition Low salt diet
Medical Jaundice – urseodoexycholic acid , Ascites – Diuretics Hepatic encephlopathy – laxatives, Autoimmune – steroids Renal failure - Haemodialysis Rastionalise pharmacy Omeprazole
Surgical• TIPSS• Liver transplantation
Multidisciplinerary Team• GP• Psychiatrist• Gastroenterology• Social services• Physiotherapy• Dietician• Specialist nurses
Prognosis5 year survival rate is 50%Post-transplant 5 year survival 65%
Prognosis
References Kumar and Clarke, Clinical Medicine Oxford Clinical Handbook of Medicine Washington Hepatitis Study NICE guidelines albumen dialysis NICE guidance living donor liver transplant Review article: the modern management of hepatic
encephalopathy by Bhajaj Netters anatomy Child-Pugh scoring article by Child and Pugh BMJ learning – liver disease module Doctors
Consultant S Ramcharan, M Osborne, Dr Gelsthorpe Reg. K McArdle, J. Barnes SHO T. Nash
THANK YOUAny questions?